Cargando…

Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists

We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT(1A) and 5-HT(2A) receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HT(1A)R K(i) for three ligands and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostrowska, Kinga, Leśniak, Anna, Czarnocka, Zuzanna, Chmiel, Jagoda, Bujalska-Zadrożny, Magdalena, Trzaskowski, Bartosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996328/
https://www.ncbi.nlm.nih.gov/pubmed/33668396
http://dx.doi.org/10.3390/ph14030179
_version_ 1783670092417990656
author Ostrowska, Kinga
Leśniak, Anna
Czarnocka, Zuzanna
Chmiel, Jagoda
Bujalska-Zadrożny, Magdalena
Trzaskowski, Bartosz
author_facet Ostrowska, Kinga
Leśniak, Anna
Czarnocka, Zuzanna
Chmiel, Jagoda
Bujalska-Zadrożny, Magdalena
Trzaskowski, Bartosz
author_sort Ostrowska, Kinga
collection PubMed
description We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT(1A) and 5-HT(2A) receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HT(1A)R K(i) for three ligands and 5-HT(2A)R Ki for one ligand as well as numerous low nanomolar estimates of K(i) for both receptors. Intrigued by these results we synthesized all 60 new derivatives using microwave-assisted protocols. We show that three new compounds show a relatively high antagonistic activity against the 5HT(1A) receptor, although lower than the reference compound WAY-100635. These compounds also showed relatively low binding affinities to the 5-HT(2A) receptor. We also provide a detailed structure–activity analysis of this series of compounds and compare it with previously obtained results for an exhaustive series of coumarin derivatives.
format Online
Article
Text
id pubmed-7996328
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79963282021-03-27 Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists Ostrowska, Kinga Leśniak, Anna Czarnocka, Zuzanna Chmiel, Jagoda Bujalska-Zadrożny, Magdalena Trzaskowski, Bartosz Pharmaceuticals (Basel) Article We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT(1A) and 5-HT(2A) receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HT(1A)R K(i) for three ligands and 5-HT(2A)R Ki for one ligand as well as numerous low nanomolar estimates of K(i) for both receptors. Intrigued by these results we synthesized all 60 new derivatives using microwave-assisted protocols. We show that three new compounds show a relatively high antagonistic activity against the 5HT(1A) receptor, although lower than the reference compound WAY-100635. These compounds also showed relatively low binding affinities to the 5-HT(2A) receptor. We also provide a detailed structure–activity analysis of this series of compounds and compare it with previously obtained results for an exhaustive series of coumarin derivatives. MDPI 2021-02-24 /pmc/articles/PMC7996328/ /pubmed/33668396 http://dx.doi.org/10.3390/ph14030179 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Ostrowska, Kinga
Leśniak, Anna
Czarnocka, Zuzanna
Chmiel, Jagoda
Bujalska-Zadrożny, Magdalena
Trzaskowski, Bartosz
Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
title Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
title_full Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
title_fullStr Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
title_full_unstemmed Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
title_short Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
title_sort design, synthesis, and biological evaluation of a series of 5- and 7-hydroxycoumarin derivatives as 5-ht(1a) serotonin receptor antagonists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996328/
https://www.ncbi.nlm.nih.gov/pubmed/33668396
http://dx.doi.org/10.3390/ph14030179
work_keys_str_mv AT ostrowskakinga designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists
AT lesniakanna designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists
AT czarnockazuzanna designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists
AT chmieljagoda designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists
AT bujalskazadroznymagdalena designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists
AT trzaskowskibartosz designsynthesisandbiologicalevaluationofaseriesof5and7hydroxycoumarinderivativesas5ht1aserotoninreceptorantagonists